Moreover, similar therapeutic synergism of the two drugs was confirmed in the remaining abovementioned TP53-mutated cell lines (HF, TMD8, VAL and Toledo) (Fig. 1C–J). The gene discussed is TP53; the disease is hydrops fetalis.